Predictors of survival after resection of retroperitoneal sarcoma: A population-based analysis and critical appraisal of the AJCC Staging system

Annals of Surgery

Volumn 250, Issue 6, 2009, Pages 970-976

  Nathan, Hari ^a   Raut, Chandrajit P ^b   Thornton, Katherine ^a   Herman, Joseph M ^a   Ahuja, Nita ^a   Schulick, Richard D ^a   Choti, Michael A ^a   Pawlik, Timothy M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Retroperitoneal sarcoma; SEER; Soft tissue sarcoma; Staging; Surgery; Survival

Indexed keywords

ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PREDICTOR VARIABLE; PRIORITY JOURNAL; RETROPERITONEAL SARCOMA; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; POSTOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROPERITONEAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA; SEER PROGRAM; SURVIVAL RATE; TIME FACTORS; UNITED STATES; YOUNG ADULT;

EID: 73449143153     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181b25183     Document Type: Article

References (38)

1. Catton CN, O'Sullivan B, Kotwall C, et al. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 1994;29: 1005-1010.
2. Singer S, Corson JM, Demetri GD, et al. Prognostic factors predictive of survival for truncal and retroperitoneal soft-tissue sarcoma. Ann Surg. 1995; 221:185-195.
3. Heslin MJ, Lewis JJ, Nadler E, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol. 1997;15:2832-2839.
4. Lewis JJ, Leung D, Woodruff JM, et al. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228:355-365.
5. Stoeckle E, Coindre JM, Bonvalot S, et al. Prognostic factors in retroperito-neal sarcoma: a multivariate analysis of a series of 165 patients of the French Cancer Center Federation Sarcoma Group. Cancer. 2001;92:359-368.
6. Ferrario T, Karakousis CP. Retroperitoneal sarcomas: grade and survival. Arch Surg. 2003;138:248-251.
7. van Dalen T, Hennipman A, van Coevorden F, et al. Evaluation of a clinically applicable post-surgical classification system for primary retroperitoneal soft-tissue sarcoma. Ann Surg Oncol. 2004;11:483-490.
8. Gronchi A, Casali PG, Fiore M, et al. Retroperitoneal soft tissue sarcomas: patterns of recurrence in 167 patients treated at a single institution. Cancer. 2004;100:2448-2455.
9. Perez EA, Gutierrez JC, Moffat FL Jr, et al. Retroperitoneal and truncal sarcomas: prognosis depends upon type not location. Ann Surg Oncol. 2007;14:1114-1122.
10. Gronchi A, Lo Vullo S, Fiore M, et al. Aggressive surgical policies in a retrospectively reviewed single-institution case series of retroperitoneal soft tissue sarcoma patients. J Clin Oncol. 2009;27:24-30.
11. Bonvalot S, Rivoire M, Castaing M, et al. Primary retroperitoneal sarcomas: a multivariate analysis of surgical factors associated with local control. J Clin Oncol. 2009;27:31-37.
12. Porter GA, Baxter NN, Pisters PW. Retroperitoneal sarcoma: a population-based analysis of epidemiology, surgery, and radiotherapy. Cancer. 2006; 106:1610-1616.
13. Greene FL, Page DL, Fleming ID, et al. AJCC Cancer Staging Manual. 6 ed. New York: Springer-Verlag; 2002.
14. Ramanathan RC, A'Hern R, Fisher C, et al. Modified staging system for extremity soft tissue sarcomas. Ann Surg Oncol. 1999;6:57-69.
15. Brennan MF. Staging of soft tissue sarcomas. Ann Surg Oncol. 1999;6:8-9.
16. Nathan H, Pawlik TM. Limitations of claims and registry data in surgical oncology research. Ann Surg Oncol. 2008;15:415-423.
17. Fritz AG. International Classification of Diseases for Oncology: ICD-O. 3rd ed. Geneva: World Health Organization; 2000.
18. Broders AC, Hargrave R, Meyerding HW. Pathological features of soft tissue fibrosarcoma with special reference to the grading of its malignancy. Surg Gynecol Obstet. 1939;69:267-280.
19. Angervall L, Kindblom LG, Rydholm A, et al. The diagnosis and prognosis of soft tissue tumors. Semin Diagn Pathol. 1986;3:240-258.
20. Costa J, Wesley RA, Glatstein E, et al. The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer. 1984;53:530-541.
21. Trojani M, Contesso G, Coindre JM, et al. Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopatholog-ical grading system. Int J Cancer. 1984;33:37-42.
22. National Cancer Institute. SEER Program Coding and Staging Manual 2007. Available at: http://seer.cancer.gov/tools/codingmanuals/index.html. Accessed March 27, 2009.
23. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
24. Cox DR. Regression models and life-tables. J Royal Stat Soc B. 1972;34: 187-220.
25. Akaike H. A new look at the statistical model identification. IEEE Trans Automat Contr. 1974;19:716-723.
26. Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8: 3-15.
27. Rubin DB. Multiple Imputation for Nonresponse in Surveys. Hoboken, NJ: Wiley-Interscience; 2004.
28. Clark TG, Altman DG. Developing a prognostic model in the presence of missing data: an ovarian cancer case study. J Clin Epidemiol. 2003;56:28-37.
29. Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361-387.
30. Anaya DA, Lev DC, Pollock RE. The role of surgical margin status in retroperitoneal sarcoma. J Surg Oncol. 2008;98:607-610.
31. Mendenhall WM, Zlotecki RA, Hochwald SN, et al. Retroperitoneal soft tissue sarcoma. Cancer. 2005;104:669-675.
32. Kattan MW, Leung DH, Brennan MF. Postoperative nomogram for 12-year sarcoma-specific death. J Clin Oncol. 2002;20:791-796.
33. Dalal KM, Kattan MW, Antonescu CR, et al. Subtype specific prognostic nomogram for patients with primary liposarcoma of the retroperitoneum, extremity, or trunk. Ann Surg. 2006;244:381-391.
34. Kane JM III. At the crossroads for retroperitoneal sarcomas: the future of clinical trials for this "orphan disease." Ann Surg Oncol. 2006;13:442-443.
35. Kaushal A, Citrin D. The role of radiation therapy in the management of sarcomas. Surg Clin North Am. 2008;88:629-646, viii.
36. Lahat G, Tuvin D, Wei C, et al. New perspectives for staging and prognosis in soft tissue sarcoma. Ann Surg Oncol. 2008;15:2739-2748.
37. Brennan MF. Staging of soft tissue sarcoma: what is new? Ann Surg Oncol. 2008;15:2643.
38. Anaya DA, Lahat G, Liu J, et al. Multifocality in retroperitoneal sarcoma: a prognostic factor critical to surgical decision-making. Ann Surg. 2009;249: 137-142.